Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02938377Phase 4Completed
Phase 4, open-label trial (3 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Audit-C Score at 18 months. Started Nov 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02938377.